Nanotein Technologies

Developer of ex vivo cell therapy technology designed for the expansion of T cells to support cancer treatment development. The company features engineered protein nanoparticles capable of conjugating multiple antibodies or cytokines, enhancing the quality and longevity of T cells, enabling research institutions and medical developers to advance cell therapy efficacy.